These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11012708)

  • 21. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
    Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
    Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of pregnancy in women with factor VII deficiency: A case series.
    Lee EJ; Burey L; Abramovitz S; Desancho MT
    Haemophilia; 2020 Jul; 26(4):652-656. PubMed ID: 32590881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
    Miyata N; Isaka M; Kojima H; Maniwa T; Takahashi S; Takamiya O; Ohde Y
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):177-80. PubMed ID: 25056454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency.
    O'Rourke N; Lee C; Kodali BS; Harnett M
    Can J Anaesth; 2006 May; 53(5):528-9. PubMed ID: 16636044
    [No Abstract]   [Full Text] [Related]  

  • 26. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.
    Jiménez-Yuste V; Villar A; Morado M; Canales M; Hernández MC; Sanjurjo MJ; Quintana M; Hernández-Navarro F
    Haemophilia; 2000 Sep; 6(5):588-90. PubMed ID: 11012708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is prophylaxis required for delivery in women with factor VII deficiency?
    Baumann Kreuziger LM; Morton CT; Reding MT
    Haemophilia; 2013 Nov; 19(6):827-32. PubMed ID: 23607277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
    Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
    Mullighan CG; Rischbieth A; Duncan EM; Lloyd JV
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):347-51. PubMed ID: 15166922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
    Hunault M; Bauer KA
    Semin Thromb Hemost; 2000; 26(4):401-5. PubMed ID: 11092215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
    Mathew P; Young G
    Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VII deficiency and pregnancy: a case report and review of literature.
    Zaidi SM; Qureshi RN; Adil SN
    J Pak Med Assoc; 2010 Feb; 60(2):136-8. PubMed ID: 20209704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia-A Case Series and Review of the Literature.
    Krzyżanowski A; Gęca T; Sokołowska B; Kwiatek M; Miturski A; Stupak A; Terlecki P; Paluszkiewicz P; Kwaśniewska A
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078653
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant activated factor VII in patients at high risk of bleeding.
    Kubisz P; Stasko J
    Hematology; 2004; 9(5-6):317-32. PubMed ID: 15763970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
    Lapecorella M; Mariani G;
    Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.